E3 Ubiquitin Ligase UBR5 Drives the Growth and Metastasis of Triple-Negative Breast Cancer.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Cancer Research

• Publication date

  2017-04-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-16-2409PMID 28330927
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PTK6 Inhibition Suppresses Metastases of Triple-Negative Breast Cancer via SNAIL-Dependent E-Cadherin Regulation.

  2016cited by this paper
• Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease

  2016cited by this paper
• Different levels of Twist1 regulate skin tumor initiation, stemness, and progression.

  2015cited by this paper
• Breast cancer cell adhesome and degradome interact to drive metastasis

  2015cited by this paper
• Functional Roles of the E3 Ubiquitin Ligase UBR5 in Cancer

  2015cited by this paper
• Systems level-based RNAi screening by high content analysis identifies UBR5 as a regulator of estrogen receptor-α protein levels and activity

  2014cited by this paper
• EDD enhances cell survival and cisplatin resistance and is a therapeutic target for epithelial ovarian cancer.

  2014cited by this paper
• Molecular mechanisms of epithelial–mesenchymal transition

  2014cited by this paper
• Oncogenic roles of EMT-inducing transcription factors

  2014cited by this paper
• A functional genomic approach reveals the transcriptional role of EDD in the expression and function of angiogenesis regulator ACVRL1.

  2013cited by this paper
• A complex containing LPP and &agr;-actinin mediates TGF&bgr;-induced migration and invasion of ErbB2-expressing breast cancer cells

  2013cited by this paper
• The Paradox of E-Cadherin: Role in response to hypoxia in the tumor microenvironment and regulation of energy metabolism

  2013cited by this paper
• Mesenchymal–epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer

  2012cited by this paper
• Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1.

  2012cited by this paper
• T-regulatory cells: key players in tumor immune escape and angiogenesis.

  2012cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• Tumor metastasis: molecular insights and evolving paradigms.

  2011cited by this paper
• Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells

  2011cited by this paper
• Immunohistochemical study of E-cadherin and β-catenin expression in colorectal carcinomas.

  2011cited by this paper
• The ins and outs of the epithelial to mesenchymal transition in health and disease.

  2011cited by this paper
• Mechanism of the Mesenchymal–Epithelial Transition and Its Relationship with Metastatic Tumor Formation

  2011cited by this paper
• Triple-negative breast cancer.

  2010cited by this paper
• miR-200 Enhances Mouse Breast Cancer Cell Colonization to Form Distant Metastases

  2009cited by this paper
• Molecular mechanisms controlling E-cadherin expression in breast cancer.

  2009cited by this paper
• Epithelial-mesenchymal transition and cell cooperativity in metastasis.

  2009cited by this paper
• The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs

  2009cited by this paper
• E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas

  2008cited by this paper
• Epithelial–mesenchymal transition (EMT) is not sufficient for spontaneous murine breast cancer metastasis

  2008cited by this paper
• TNFR1 signaling and IFN-gamma signaling determine whether T cells induce tumor dormancy or promote multistage carcinogenesis.

  2008cited by this paper
• Signaling through ShcA Is Required for Transforming Growth Factor β- and Neu/ErbB-2-Induced Breast Cancer Cell Motility and Invasion

  2008cited by this paper
• The presence of tumor-infiltrating FOXP3+ lymphocytes correlates with intratumoral angiogenesis in endometrial cancer.

  2008cited by this paper
• The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro

  2008cited by this paper
• Mesenchymal to Epithelial Transition in Development and Disease

  2007cited by this paper
• Expression pattern of adhesion molecules (E‐cadherin, α‐, β‐, γ‐catenin and claudin‐7), their influence on survival in primary breast carcinoma, and their corresponding axillary lymph node metastasis

  2007cited by this paper
• Expression pattern of adhesion molecules (E-cadherin, alpha-, beta-, gamma-catenin and claudin-7), their influence on survival in primary breast carcinoma, and their corresponding axillary lymph node metastasis.

  2007cited by this paper
• Intratumoral FOXP3 expression in infiltrating breast carcinoma: Its association with clinicopathologic parameters and angiogenesis.

  2007cited by this paper
• In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro

  2007cited by this paper
• Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.

  2007cited by this paper
• Sulforhodamine B colorimetric assay for cytotoxicity screening

  2006cited by this paper
• Metastasis: a question of life or death

  2006cited by this paper
• Evaluation of tumor angiogenesis measured with microvessel density (MVD) as a prognostic indicator in nasopharyngeal carcinoma: results of RTOG 9505.

  2005cited by this paper
• Edd, the Murine Hyperplastic Disc Gene, Is Essential for Yolk Sac Vascularization and Chorioallantoic Fusion

  2004cited by this paper
• Vascular Endothelial Growth Factor and Angiogenesis

  2004cited by this paper
• EDD, the human orthologue of the hyperplastic discs tumour suppressor gene, is amplified and overexpressed in cancer

  2003cited by this paper
• EDD, the Human Hyperplastic Discs Protein, Has a Role in Progesterone Receptor Coactivation and Potential Involvement in DNA Damage Response*

  2002cited by this paper
• Metastasis: Dissemination and growth of cancer cells in metastatic sites

  2002cited by this paper
• Hedgehog is required for murine yolk sac angiogenesis.

  2002cited by this paper
• E-cadherin as a prognostic indicator in primary breast cancer

  2001cited by this paper
• CD4+ T cell--mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells.

  2000cited by this paper
• Mouse 4T1 Breast Tumor Model

  2000cited by this paper
• An immunohistochemical examination of the expression of E-cadherin, alpha- and beta/gamma-catenins, and alpha2- and beta1-integrins in invasive breast cancer.

  1999cited by this paper
• An immunohistochemical examination of the expression of E‐cadherin, α‐ and β/γ‐catenins, and α2‐ and β1‐integrins in invasive breast cancer

  1999cited by this paper
• Immunoproteasome Assembly: Cooperative Incorporation of Interferon γ (IFN-γ)–inducible Subunits

  1998cited by this paper
• Identification of a human HECT family protein with homology to the Drosophila tumor suppressor gene hyperplastic discs

  1998cited by this paper
• Epithelial and stromal estrogen and progesterone receptor expression in endometrial cancer: true color computer-assisted image analysis versus subjective scoring.

  1997cited by this paper
• Expression of E‐cadherin (E‐CD) as related to other prognostic factors and survival in breast cancer

  1994cited by this paper

• UBR5, a potential diagnostic and prognostic biomarker induces osteosarcoma progression.

  2026cites this paper
• USP49 promotes the malignancy of triple-negative breast cancer cells by regulating PKMYT1 ubiquitination and stability.

  2025cites this paper
• The multifaceted role of E3 ubiquitin ligases in cancer metastasis: mechanisms, targets, and therapeutic implications

  2025cites this paper
• Application of Gene Editing Technology Based on Targeted Delivery Materials in TNBC

  2025cites this paper
• UBR5 antagonizes DNA damage to enhance the doxorubicin resistance of triple-negative breast cancer by p38 signaling

  2025cites this paper
• A Novel Prognostic Signature of Mitophagy-Related E3 Ubiquitin Ligases in Breast Cancer

  2025cites this paper
• UBR5 in Tumor Biology: Exploring Mechanisms of Immune Regulation and Possible Therapeutic Implications in MPNST

  2025influential citation
• MicroRNAs as behind-the-scenes molecules in breast cancer metastasis and their therapeutic role through novel microRNA-based delivery strategies.

  2025cites this paper
• E3 Ubiquitin Ligases and Their Therapeutic Applications in Cancers: Narrative Review

  2024cites this paper
• E3 ubiquitin ligase UBR5 modulates circadian rhythm by facilitating the ubiquitination and degradation of the key clock transcription factor BMAL1

  2024cites this paper
• A review: targeting UBR5 domains to mediate emerging roles and mechanisms – chance or necessity?

  2024cites this paper
• SF3A2 promotes progression and cisplatin resistance in triple-negative breast cancer via alternative splicing of MKRN1

  2024cites this paper
• CRISPR/Cas9: an overview of recent developments and applications in cancer research

  2024cites this paper
• The role of UBR5 in tumor proliferation and oncotherapy.

  2024cites this paper
• Spermatid perinuclear RNA-binding protein promotes UBR5-mediated proteolysis of Dicer to accelerate triple-negative breast cancer progression.

  2024cites this paper
• Involvement of the ubiquitin-proteasome system in the regulation of the tumor microenvironment and progression

  2024cites this paper
• SUB1 promotes colorectal cancer metastasis by activating NF-κB signaling via UBR5-mediated ubiquitination of UBXN1

  2024cites this paper
• Targeting mammalian N-end rule pathway for cancer therapy.

  2024cites this paper
• UBR-5 and UBE2D mediate timely exit from stem fate via destabilization of poly(A)-binding protein PABP-2 in cell state transition

  2024cites this paper
• Crocin Inhibited Epithelial-Mesenchymal Transition in Renal Tubular Epithelial Cells to Treat Diabetic Nephropathy Through Improving AMPK/mTOR-Mediated Autophagy

  2024cites this paper
• DMDD, isolated from Averrhoa carambola L., ameliorates diabetic nephropathy by regulating endoplasmic reticulum stress-autophagy crosstalk

  2024cites this paper
• UBR5 mediates colorectal cancer chemoresistance by attenuating ferroptosis via Lys 11 ubiquitin-dependent stabilization of Smad3-SLC7A11 signaling

  2024influential citation
• TRIM8 promotes ovarian cancer proliferation and migration by targeting VDAC2 for ubiquitination and degradation

  2024cites this paper
• The E3 ubiquitin ligases regulate PD-1/PD-L1 protein levels in tumor microenvironment to improve immunotherapy

  2023cites this paper
• Unraveling Roles of miR-27b-3p as a Potential Biomarker for Breast Cancer in Malay Women via Bioinformatics Analysis

  2023cites this paper
• Emerging Futuristic Targeted Therapeutics

  2023influential citation
• Targeting UBR5 inhibits postsurgical breast cancer lung metastases by inducing CDC73 and p53 mediated apoptosis

  2023cites this paper
• Orphan quality control shapes network dynamics and gene expression.

  2023cites this paper
• Structure of the human UBR5 E3 ubiquitin ligase.

  2023cites this paper
• CRISPR/Cas9 as a therapeutic tool for triple negative breast cancer: from bench to clinics

  2023cites this paper
• Cryo‐EM structure of the chain‐elongating E3 ubiquitin ligase UBR5

  2023cites this paper
• The ubiquitin-proteasome system in breast cancer.

  2023cites this paper
• Structural snapshots along K48-linked ubiquitin chain formation by the HECT E3 UBR5

  2023cites this paper
• The role and molecular mechanism of metabolic reprogramming of colorectal cancer by UBR5 through PYK2 regulation of OXPHOS expression study

  2023cites this paper
• Molecular landscape and emerging therapeutic strategies in breast cancer brain metastasis

  2023cites this paper
• Exploiting E3 ubiquitin ligases to reeducate the tumor microenvironment for cancer therapy

  2023cites this paper
• The various role of microRNAs in breast cancer angiogenesis, with a special focus on novel miRNA-based delivery strategies

  2023cites this paper
• CRISPR/Cas genome editing in triple negative breast cancer: Current situation and future directions.

  2023cites this paper
• Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA

  2023cites this paper
• Genomic screening reveals ubiquitin-like modifier activating enzyme 1 as a potent and druggable target in c-MYC-high triple negative breast cancer models

  2022cites this paper
• UBR5 targets tumor suppressor CDC73 proteolytically to promote aggressive breast cancer

  2022cites this paper
• Retinitis pigmentosa 2 pathogenic mutants degrade through BAG6/HUWE1 complex.

  2022cites this paper
• ROS1 altered breast cancers – a distinctive molecular subtype of PR- metastatic breast cancers: Expanding the scope of targeted therapeutics

  2022cites this paper
• Triple-negative breast cancer drug resistance, durable efficacy, and cure: how advanced biological insights and emerging drug modalities could transform progress

  2022cites this paper
• UBR5 promotes tumor immune evasion through enhancing IFN-γ-induced PDL1 transcription in triple negative breast cancer

  2022cites this paper
• CircUBR5 acts as a ceRNA for miR-1179 to up-regulate UBR5 and to promote malignancy of triple-negative breast cancer.

  2022cites this paper
• UBR5 promotes migration and invasion of glioma cells by regulating the ECRG4/NF-κB pathway

  2022cites this paper
• CRISPR/Cas9 system in breast cancer therapy: advancement, limitations and future scope

  2022cites this paper
• UBR5 Acts as an Antiviral Host Factor against MERS-CoV via Promoting Ubiquitination and Degradation of ORF4b

  2022cites this paper
• Obstacles for T-lymphocytes in the tumour microenvironment: Therapeutic challenges, advances and opportunities beyond immune checkpoint

  2022cites this paper
• Myoglobin mutant with enhanced nitrite reductase activity regulates intracellular oxidative stress in human breast cancer cells.

  2022cites this paper
• Clinicopathological Features and Prognostic Evaluation of UBR5 in Liver Cancer Patients

  2022cites this paper
• Structure of the human UBR5 E3 ubiquitin ligase

  2022cites this paper
• Orphan quality control shapes network dynamics and gene expression

  2022cites this paper
• Roles of transducin-like enhancer of split (TLE) family proteins in tumorigenesis and immune regulation

  2022cites this paper
• Application of the CRISPR/Cas9-based gene editing technique in basic research, diagnosis, and therapy of cancer

  2021cites this paper
• Will CRISPR-Cas9 Have Cards to Play Against Cancer? An Update on its Applications

  2021cites this paper
• BoxCar and shotgun proteomic analyses reveal molecular networks regulated by UBR5 in prostate cancer

  2021cites this paper
• Research Progress, Challenges, and Breakthroughs of Organoids as Disease Models

  2021cites this paper
• E3 Ubiquitin Ligases in Breast Cancer Metastasis: A Systematic Review of Pathogenic Functions and Clinical Implications

  2021cites this paper
• Epithelioid leiomyosarcoma of broad ligament harboring PGR-NR4A3 and UBR5-PGR gene fusions: a unique case report

  2021cites this paper
• CRISPR/Cas9 in cancer therapy: A review with a special focus on tumor angiogenesis.

  2021cites this paper
• A novel CD74-ROS1 gene fusion in a patient with inflammatory breast cancer: a case report

  2021cites this paper
• New Insights into the Therapeutic Applications of CRISPR/Cas9 Genome Editing in Breast Cancer

  2021cites this paper
• CRISPR/Cas9 based genome editing for targeted transcriptional control in triple-negative breast cancer

  2021cites this paper
• TMT based deep proteome analysis of buffalo mammary epithelial cells and identification of novel protein signatures during lactogenic differentiation

  2021cites this paper
• UBR5 inhibits the radiosensitivity of non-small cell lung cancer cells via the activation of the PI3K/AKT pathway

  2021cites this paper
• Combining UBR5 and CD163+ tumor-associated macrophages better predicts prognosis of clear cell renal cell carcinoma patients

  2021cites this paper
• E3 Ubiquitin Ligase UBR5 Promotes the Metastasis of Pancreatic Cancer via Destabilizing F-Actin Capping Protein CAPZA1

  2021cites this paper
• Targeting the Ubiquitin Signaling Cascade in Tumor Microenvironment for Cancer Therapy

  2021cites this paper
• Ubiquitin, SUMO, and Nedd8 as Therapeutic Targets in Cancer.

  2020cites this paper
• Desorption Electrospray Ionization Mass Spectrometry Imaging for Tissue Analysis

  2020cites this paper
• Tumor derived UBR5 promotes ovarian cancer growth and metastasis through inducing immunosuppressive macrophages

  2020cites this paper
• E3 ubiquitin ligase UBR5 promotes pancreatic cancer growth and aerobic glycolysis by downregulating FBP1 via destabilization of C/EBPα

  2020cites this paper
• Prognostic Roles of Neutrophil-to-Lymphocyte Ratio and Stromal Tumor-Infiltrating Lymphocytes and Their Relationship in Locally Advanced Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy

  2020cites this paper
• scATAC-Seq reveals epigenetic heterogeneity associated with an EMT-like process in male germline stem cells and its regulation by G9a

  2020cites this paper
• UBR5 over-expression contributes to poor prognosis and tamoxifen resistance of ERa+ breast cancer by stabilizing β-catenin

  2020cites this paper
• The Impact of CRISPR-Cas9 on Age-related Disorders: From Pathology to Therapy

  2020cites this paper
• UBR-box containing protein, UBR5, is over-expressed in human lung adenocarcinoma and is a potential therapeutic target

  2020cites this paper
• Targeting ubiquitin protein ligase E3 component N-recognin 5 in cancer cells induces a CD8+ T cell mediated immune response

  2020influential citation
• A novel single-cell based method for breast cancer prognosis

  2020cites this paper
• E3 Ligase, UBR5, HECT domain mutations in lymphoma control maturation of B cells.

  2020cites this paper
• HECT E3 ubiquitin ligases – emerging insights into their biological roles and disease relevance

  2020cites this paper
• Mitigating off-target effects in CRISPR/Cas9-mediated in vivo gene editing

  2020cites this paper
• Progress in triple negative breast carcinoma pathophysiology: Potential therapeutic targets.

  2020cites this paper
• UBR5 Is Coamplified with MYC in Breast Tumors and Encodes an Ubiquitin Ligase That Limits MYC-Dependent Apoptosis

  2020cites this paper
• PI3K/AKT/mTOR pathway inhibitors in triple-negative breast cancer: a review on drug discovery and future challenges.

  2019cites this paper
• E3 Ligase UBR5 HECT domain mutations in lymphoma control maturation of B cells via alternative splicing

  2019cites this paper
• Overexpression of UBR5 promotes tumor growth in gallbladder cancer via PTEN/PI3K/Akt signal pathway

  2019cites this paper
• Application of CRISPR/Cas9 gene editing technique in the study of cancer treatment

  2019cites this paper
• Prolactin-inducible EDD E3 ubiquitin ligase promotes TORC1 signalling, anti-apoptotic protein expression, and drug resistance in breast cancer cells.

  2019cites this paper
• Control of MYC-dependent apoptotic threshold by a co-amplified ubiquitin E3 ligase UBR5

  2019cites this paper
• CRISPR/Cas9: a powerful tool for identification of new targets for cancer treatment.

  2019cites this paper
• Cluster of differentiation 147 mediates chemoresistance in breast cancer by affecting vacuolar H+-ATPase expression and activity.

  2018cites this paper
• CRISPR Technology for Breast Cancer: Diagnostics, Modeling, and Therapy

  2018cites this paper
• Xi Qiao: REGULATION OF MYC ACTIVITY BY POST-TRANSLATIONAL MODIFICATIONS

  2018cites this paper
• Break Breast Cancer Addiction by CRISPR/Cas9 Genome Editing

  2018cites this paper
• MEK inhibitor, PD98059, promotes breast cancer cell migration by inducing β-catenin nuclear accumulation.

  2017cites this paper
• Significance of the E3 ubiquitin protein UBR5 as an oncogene and a prognostic biomarker in colorectal cancer

  2017cites this paper